Sell on news ... Sales have not begun yet. T
Post# of 1782
Posted On: 07/26/2016 1:36:49 PM
Sell on news ...
Sales have not begun yet.
T-Trades will force this under .01
No news on debt restructuring
FREEHOLD, NJ -- (Marketwired) -- 07/26/16 -- MEDIFIRST SOLUTIONS, INC. (OTC PINK: MFST) (the "Company" or "Medifirst"
would like to update shareholders regarding its new stage of operations. As recently announced, Medifirst Solutions, Inc., in response to its Premarket Notification 510(k) submission, received clearance from the U.S. Food and Drug Administration ("FDA" to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device.
As part of the pre-sales and marketing rollout of the Laser Series, Medifirst has begun to implement internal controls and procedures as mandated by the FDA. These controls and procedures include in-office checks and balances, as well as those required at its manufacturer, and must be implemented prior to initiating sales. The Company is aggressively putting together a sales & distribution team to offer its lasers in the US market. The team will be made up of seasoned professionals with experience in the sales and marketing of medical devices that will initially focus on targeting and analyzing the specific markets and sectors to which to market its products. Additionally, as part of a corporate restructure the company will be appointing Board Members with well-established credentials in the medical device Industry as well as established and renowned industry professionals from the business and financial community. Medifirst has plans to add a CFO and additional officers to its corporate operations. These announcements are forthcoming.
Commented President Bruce J. Schoengood, "The reaction to our FDA clearance has simply been overwhelming. We are aggressively working to ramp up operations and meet all FDA requirements. We have been contacted by healthcare professionals regarding sales, which will be implemented after FDA compliance is complete. I am also pleased that we will be adding many industry leaders to our Board of Directors, as well as adding to our advisory board. This is a very exciting time and we appreciate the continued support of our shareholders."
Report TOS
Sales have not begun yet.
T-Trades will force this under .01
No news on debt restructuring
FREEHOLD, NJ -- (Marketwired) -- 07/26/16 -- MEDIFIRST SOLUTIONS, INC. (OTC PINK: MFST) (the "Company" or "Medifirst"
would like to update shareholders regarding its new stage of operations. As recently announced, Medifirst Solutions, Inc., in response to its Premarket Notification 510(k) submission, received clearance from the U.S. Food and Drug Administration ("FDA" to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. As part of the pre-sales and marketing rollout of the Laser Series, Medifirst has begun to implement internal controls and procedures as mandated by the FDA. These controls and procedures include in-office checks and balances, as well as those required at its manufacturer, and must be implemented prior to initiating sales. The Company is aggressively putting together a sales & distribution team to offer its lasers in the US market. The team will be made up of seasoned professionals with experience in the sales and marketing of medical devices that will initially focus on targeting and analyzing the specific markets and sectors to which to market its products. Additionally, as part of a corporate restructure the company will be appointing Board Members with well-established credentials in the medical device Industry as well as established and renowned industry professionals from the business and financial community. Medifirst has plans to add a CFO and additional officers to its corporate operations. These announcements are forthcoming.
Commented President Bruce J. Schoengood, "The reaction to our FDA clearance has simply been overwhelming. We are aggressively working to ramp up operations and meet all FDA requirements. We have been contacted by healthcare professionals regarding sales, which will be implemented after FDA compliance is complete. I am also pleased that we will be adding many industry leaders to our Board of Directors, as well as adding to our advisory board. This is a very exciting time and we appreciate the continued support of our shareholders."
Report TOS
(0)
(0)Medifirst Solutions Inc. (MFST) Stock Research Links
Scroll down for more posts ▼